Clinical features and outcomes of IgA nephropathy with nephrotic syndrome

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 3, 2012, Pages 427-436

  Kim, Jwa Kyung ^a   Kim, Jeong Ho ^b   Lee, Sang Choel ^c   Kang, Ea Wha ^b   Chang, Tae Ik ^b   Moon, Sung Jin ^c   Yoon, Soo Young ^c   Yoo, Tae Hyun ^a   Kang, Shin Wook ^a   Choi, Kyu Hun ^a   Han, Dae Suk ^a   Kie, Jeong Hae ^b   Lim, Beom Jin ^a   Jeong, Hyeon Joo ^a   Han, Seung Hyeok ^a  

^a Yonsei University College of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

^c Kwandong University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CREATININE;

ADULT; ARTICLE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; GENERALIZED EDEMA; HEMATURIA; HEPATITIS B; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPOALBUMINEMIA; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KOREA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROTIC SYNDROME; OBSERVATIONAL STUDY; OSTEOPOROSIS; OUTCOME ASSESSMENT; PROGNOSIS; PROTEINURIA; REMISSION; STOMACH ULCER;

ADULT; BIOLOGICAL MARKERS; BIOPSY; CHI-SQUARE DISTRIBUTION; CREATININE; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REMISSION INDUCTION; REMISSION, SPONTANEOUS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION; YOUNG ADULT;

EID: 84863250467     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04820511     Document Type: Article

References (30)

1. Reich HN, Troyanov S, Scholey JW, Cattran DC Toronto Glomerulonephritis Registry: Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 18: 3177-3183, 2007
2. Donadio JV, Grande JP: IgA nephropathy. N Engl J Med 347: 738-748, 2002
3. Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP: Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 8: 199-207, 1997
4. Samuels JA, Strippoli GF, Craig JC, Schena FP, Molony DA: Immunosuppressive treatments for immunoglobulin A nephropathy: A meta-analysis of randomized controlled trials. Nephrology (Carlton) 9: 177-185, 2004
5. Delclaux C, Jacquot C, Callard P, Kleinknecht D: Acute reversible renal failure with macroscopic haematuria in IgA nephropathy. Nephrol Dial Transplant 8: 195-199, 1993
6. Nachman PH, Jennette JC, Falk RJ: Primary glomerular disease. In: Brenner&Rector's The Kidney, 8th Ed., edited by BrennerBM, Philadelphia, Saunders Elsevier, 2008, pp 1024-1032
7. Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM: Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant 17: 1197-1203, 2002
8. Lai KN, Lai FM, Chan KW, Ho CP, Leung AC, Vallance-Owen J: An overlapping syndrome of IgA nephropathy and lipoid nephrosis. Am J Clin Pathol 86: 716-723, 1986
9. Sinnassamy P, O'Regan S: Mesangial IgA deposits with steroid responsive nephrotic syndrome: Probable minimal lesion nephrosis. Am J Kidney Dis 5: 267-269, 1985
10. Choi J, Jeong HJ, Lee HY, Kim PK, Lee JS, Han DS: Significance of mesangial IgA deposition in minimal change nephrotic syndrome: A study of 60 cases. Yonsei Med J 31: 258-263, 1990
11. Lai KN, Lai FM, Ho CP, Chan KW: Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: A long-term controlled trial. Clin Nephrol 26: 174-180, 1986
12. Lai KN, Mac-Moune Lai F, Li PK, Chan KW, Au TC, Tong KL: The clinicopathological characteristics of IgA nephropathy in Hong Kong. Pathology 20: 15-19, 1988
13. Kim SM, Moon KC, Oh KH, Joo KW, Kim YS, Ahn C, Han JS, Kim S: Clinicopathologic characteristics of IgA nephropathy with steroid-responsive nephrotic syndrome. J Korean Med Sci 24[Suppl]: S44-S49, 2009
14. Han SH, Kang EW, Park JK, Kie JH, Han DS, Kang SW: Spontaneous remission of nephrotic syndrome in patients with IgA nephropathy. Nephrol Dial Transplant 26: 1570-1575, 2011
15. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39[Suppl 1]: S1-S266, 2002
16. Haas M: Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases. Am J Kidney Dis 29: 829-842, 1997
17. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H Working Group of the International IgA Nephropathy Network and the Renal Pathology Society: The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification. Kidney Int 76: 534-545, 2009
18. Radhakrishnan J, Appel AS, Valeri A, Appel GB: The nephrotic syndrome, lipids, and risk factors for cardiovascular disease. Am J Kidney Dis 22: 135-142, 1993
19. Cheng IK, Chan KW, Chan MK:Mesangial IgA nephropathy with steroid-responsive nephrotic syndrome: Disappearance of mesangial IgA deposits following steroid-induced remission. Am J Kidney Dis 14: 361-364, 1989
20. Mustonen J, Pasternack A, Rantala I: The nephrotic syndrome in IgA glomerulonephritis: Response to corticosteroid therapy. Clin Nephrol 20: 172-176, 1983
21. Chen YE, Korbet SM, Katz RS, Schwartz MM, Lewis EJ Collaborative Study Group: Value of a complete or partial remission in severe lupus nephritis. Clin J Am Soc Nephrol 3: 46-53, 2008
22. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC Toronto Glomerulonephritis Registry Group: Focal and segmental glomerulosclerosis: Definition and relevance of a partial remission. J Am Soc Nephrol 16: 1061-1068, 2005
23. Wu G, Katz A, Cardella C, Oreopoulos DG: Spontaneous remission of nephrotic syndrome in IgA glomerular disease. Am J Kidney Dis 6: 96-99, 1985
24. Hogg RJ, Savino DA: Spontaneous remission of nephrotic syndrome in a patient with IgA nephropathy. Pediatr Nephrol 4: 36-38, 1990
25. Jeong HJ, Jung SH, Choi IJ: Electron microscopic study of the cases of minimal change nephrotic syndromewith mesangial IgA deposition. Yonsei Med J 33: 351-356, 1992
26. Jennette JC, Heptinstall RH: Heptinstall's Pathology of the Kidney, Philadelphia, Lippincott Williams & Wilkins, 2007
27. Strippoli GF, Manno C, Schena FP: An "evidence-based" survey of therapeutic options for IgA nephropathy: Assessment and criticism. Am J Kidney Dis 41: 1129-1139, 2003
28. Bakris G, Burgess E, Weir M, Davidai G, Koval S AMADEO Study Investigators: Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy. Kidney Int 74: 364-369, 2008
29. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S RENAAL Study Investigators: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861-869, 2001
30. Geddes CC, Rauta V, Gronhagen-Riska C, Bartosik LP, Jardine AG, Ibels LS, Pei Y, Cattran DC: A tricontinental view of IgA nephropathy. Nephrol Dial Transplant 18: 1541-1548, 2003